Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
27.0%
% of ARKG's 39 holdings also in IDNA
21.3%
% of IDNA's 51 holdings also in ARKG
Overlap by Weight
Sector Drift (ARKG minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in ARKG |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
MODERNA, INC. | 3.0% | 5.0% | 3.0% | |
BEAM THERAPEUTICS, INC. | 3.9% | 2.2% | 2.2% | |
TWIST BIOSCIENCE CORP. | 6.1% | 2.1% | 2.1% | |
INCYTE CORP | 1.6% | 3.8% | 1.6% | |
GINKGO BIOWORKS HOLDINGS INC CLASS A | 3.5% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
ARKG Overweight Relative to IDNA
CRISPR THERAPEUTICS AG | 6.3% | |
EXACT SCIENCES CORP | 5.4% | |
RECURSION PHARMACEUTICALS, INC CLASS | 5.2% | |
SCHRODINGER, INC. | 4.7% | |
IONIS PHARMACEUTICALS, INC. | 4.3% | |
TWIST BIOSCIENCE CORP. | 4.0% | |
ACCOLADE, INC. | 4.0% | |
CAREDX, INC. | 3.7% | |
10X GENOMICS INC CLASS A | 3.6% | |
INTELLIA THERAPEUTICS, INC. | 3.5% |
ARKG Underweight Relative to IDNA
REVOLUTION MEDICINES, INC. | -5.6% | |
SAREPTA THERAPEUTICS INC | -5.3% | |
MERCK & CO. INC. | -4.7% | |
EXELIXIS INC | -4.0% | |
SANOFI-AVENTIS | -3.9% | |
TAKEDA PHARMACEUTICAL CO LTD | -3.6% | |
GENMAB A/S | -3.6% | |
ROCHE HOLDING LTD | -3.5% | |
BIONTECH SE SPONSORED ADR | -3.4% | |
GILEAD SCIENCES INC | -3.4% |